Autoimmune Bullous Diseases and Quality of Life
Bookmark1. Skin-related quality of life is associated with the type of autoimmune bullous disease and flare state. 2. Skin-related quality of life can inform changes in disease state and severity of...
View Article3-dimensional stereophotogrammetry for craniofacial morphea disease progression
Bookmark1. 3-dimensional (3D) stereophotogrammetry identified craniofacial morphea (CM) progression in patients with clinically reported disease activity. 2. 3D stereophotogrammetry identified the...
View ArticleSpesolimab may improve quality of life in patients with generalized pustular...
1. Efficacy of spesolimab appeared to be dose-dependent with high-dose spesolimab leading to a significantly longer time to GPP flare-up versus placebo. 2. There were no treatment-related deaths or...
View ArticleCurrent expert consensus for the treatment of adult patients with drug...
1. A large majority of experts in this study came to a unified consensus on how to approach the diagnosis and treatment of patients with drug reaction with eosinophilia and systemic symptoms (DRESS)....
View ArticleIL-23 inhibitors may have a lower risk of paradoxical eczema in comparison to...
1. Interleukin-23 inhibitors had a lower risk of developing paradoxical eczema when treated for plaque psoriasis compared to TNF inhibitors, IL-17 inhibitors and IL-12/23 2. Clinical features...
View ArticleFirst-line rituximab for pemphigus associated with long-term complete...
1. Patients with pemphigus treated with first-line rituximab showed sustained complete remission rates without corticosteroids for up to 7 years post-treatment 2. High-risk patients for pemphigus...
View ArticleInterleukin-23 receptor antagonist improves psoriasis symptoms
1. In this randomized controlled trial, treatment with JNJ-77242113 improved psoriasis symptoms as compared to a placebo. 2. JNJ-77242113 showed a dose-response relationship, with higher doses...
View ArticleRadiation treatment for breast cancer may increase incidence of...
1. Amongst a cohort of breast cancer survivors, those that were treated with radiation had a higher risk of developing nonkeratinocyte skin cancer. Evidence Rating Level: 2 (Good) Cancer remains the...
View ArticleIndividualized cancer mRNA-based cancer therapy shows benefit in patients...
1. 18-month recurrence-free survival was significantly greater in the combination therapy group compared to pembrolizumab alone. 2. There were no treatment-related grade 4-5 adverse events or...
View ArticleIntravenous ertapenem for hidradenitis suppurativa
1. Intravenous ertapenem administered for a mean of 13 weeks for patients with hidradenitis suppurativa was associated with improvement in clinical outcomes, inflammatory markers, and patient...
View Article
More Pages to Explore .....